KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Financing Activities (2016 - 2025)

Idexx Laboratories has reported Cash from Financing Activities over the past 17 years, most recently at -$355.7 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$355.7 million for Q4 2025, down 52.8% from a year ago — trailing twelve months through Dec 2025 was -$1.2 billion (down 32.67% YoY), and the annual figure for FY2025 was -$1.2 billion, down 32.67%.
  • Cash from Financing Activities for Q4 2025 was -$355.7 million at Idexx Laboratories, down from -$313.3 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for IDXX hit a ceiling of -$13.5 million in Q1 2022 and a floor of -$355.7 million in Q4 2025.
  • Median Cash from Financing Activities over the past 5 years was -$158.3 million (2023), compared with a mean of -$177.7 million.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 41763.32% in 2021 and later surged 89.6% in 2022.
  • Idexx Laboratories' Cash from Financing Activities stood at -$165.8 million in 2021, then rose by 29.61% to -$116.7 million in 2022, then grew by 12.75% to -$101.8 million in 2023, then tumbled by 128.57% to -$232.8 million in 2024, then tumbled by 52.8% to -$355.7 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$355.7 million (Q4 2025), -$313.3 million (Q3 2025), and -$165.6 million (Q2 2025) per Business Quant data.